Hans L. Mooij - Concepedia

Author

Hans L. Mooij

Amsterdam UMC Location University of Amsterdam

Also Known As

H Mooij, H. L. Mooij, H.L. Mooij, Hans L Mooij, Hans L. Mooij, Hans Mooij

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam Maastricht University Leiden University Medical Center University of Amsterdam University of California San Diego

About

Hans L. Mooij is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, vascular biology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Health Sciences	4	4	1.1K
3	Biomedical Engineering	4	4	1.3K
4	Diabetes	3	3	1.1K
5	Public Health	1	1	199

Hans L. Mooij

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo Max Nieuwdorp, Timon W. van Haeften, Mirella Gouverneur, Diabetes Mannitol InfusionBiomedical EngineeringMetabolic SyndromeEndothelial GlycocalyxHematology	2006	613
Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes Max Nieuwdorp, Hans L. Mooij, Jojanneke Kroon, Diabetes Metabolic SyndromeType 1UrologyMicrovascular GlycocalyxMedicine	2006	427
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus Lysette N. Broekhuizen, Bregtje A. Lemkes, Hans L. Mooij, Diabetologia	2010	390
Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability Max Nieuwdorp, Marijn C. Meuwese, Hans L. Mooij, Journal of Applied Physiology Vascular DiseasePathologyBiomedical EngineeringEndothelial GlycocalyxHematology	2007	199
Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation Max Nieuwdorp, Marijn C. Meuwese, Hans L. Mooij, Atherosclerosis InflammationEndothelial Cell PathobiologyMedicineVascular PharmacologyImmunology	2008	161
Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia Marijn C. Meuwese, Hans L. Mooij, Max Nieuwdorp, Journal of Lipid Research Lipid DisorderVascular DiseasePartial RecoveryCardiovascular DiseaseMedicine	2008	81
Inhibition of hepatic sulfatase-2 In Vivo : A novel strategy to correct diabetic dyslipidemia Carlijne Hassing, Hans L. Mooij, Shuling Guo, Hepatology	2012	44
<i>SULF2</i> strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus H. Carlijne Hassing, Ramya Preethi Surendran, Bruno Derudas, Obesity	2013	40
Rapid Insulin-Mediated Increase in Microvascular Glycocalyx Accessibility in Skeletal Muscle May Contribute to Insulin-Mediated Glucose Disposal in Rats Bart Eskens, Hans L. Mooij, Jack P.M. Cleutjens, PLoS ONE Microvascular Blood VolumeBiomedical EngineeringInsulin-mediated IncreasesInsulin SignalingObesity	2013	29
Loss of Function in Heparan Sulfate Elongation Genes <i>EXT1</i> and <i>EXT 2</i> Results in Improved Nitric Oxide Bioavailability and Endothelial Function Hans L. Mooij, Pedro Cabrales, Sophie J. Bernelot Moens, Journal of the American Heart Association	2014	26

Page 1